Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00287170 | Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease | PHASE1 | COMPLETED | 15 | — | — | Jul 1, 2006 | Dec 1, 2007 | Jul 8, 2008 | 1 | Israel |
| Name | Type | Description |
|---|---|---|
| Delayed Release 6MP or Calcitriol vs. Purinethol | DRUG | - |
Inclusion Criteria: * Male or Female patients, aged 18-75 years with moderate Crohn's Disease (CDAI score \>=220 and \<=400 at screening), with or without adjunctive mesalamine treatment, 12 with involvement of the ileum and three without ileal involvement * Definitive diagnosis of active inflammat...